Cell therapy for heart failure -recent progress and future directions

Overview of attention for article published in Progress in Cardiovascular Diseases, August 2025

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,780 followers.

Cell therapy works in HF patients via paracrine effects, not due to myocyte regeneration as initially believed. CATO (NCT06145035) is a Phase IIA multicenter trial of single versus repeated mesenchymal stromal cells (UC-MSCs) in patients with ischemic c…

RT @PCVDJournal: Cell therapy for heart failure -recent progress and future directions https://t.co/iILdGGbwPt @DineshKalra @JavedButler1…

Cell therapy for heart failure -recent progress and future directions https://t.co/iILdGGbwPt @DineshKalra @JavedButler1 https://t.co/o1cYGtgYDR

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.